Cargando…

Expert Insights on Triple-Negative Breast Cancer: Preparing for the Next Wave of Treatments

Heather R. Greene, MSN, FNP, AOCNP®, and Lee S. Schwartzberg, MD, FACP, discussed the current and future treatment landscape for triple-negative breast cancer, including recent and emerging data on approved treatments, novel therapeutic options being investigated, and best practices for identifying...

Descripción completa

Detalles Bibliográficos
Autores principales:	Greene, Heather R., Schwartzberg, Lee S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Harborside Press LLC 2020
Materias:	Meeting Reports
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7857324/ https://www.ncbi.nlm.nih.gov/pubmed/33598323 http://dx.doi.org/10.6004/jadpro.2020.11.3.10

Ejemplares similares

Hormone Receptor–Positive, HER2-Negative Breast Cancer: Recent Advances and Best Practices
por: Schwartzberg, Lee, et al.
Publicado: (2020)

Immunotherapy for the Treatment of Triple-Negative Breast Cancer
por: Tolaney, Sara M., et al.
Publicado: (2022)

Next-Generation Sequencing and Triple-Negative Breast Cancer: Insights and Applications
por: Tierno, Domenico, et al.
Publicado: (2023)

Optimizing treatment selection, and sequencing decisions for Management of HR-Positive, HER2-Negative advanced breast cancer – Proceedings from breast cancer expert group meeting
por: Dawood, Shaheenah, et al.
Publicado: (2021)

BRCA1 mutation in the Triple- Negative Breast Cancer Group
por: Maksimenko, Jelena, et al.
Publicado: (2012)

Use of Oral Cholera Vaccine in Complex Emergencies: What Next? Summary Report of an Expert Meeting and Recommendations of WHO
por: Chaignat, Claire-Lise, et al.
Publicado: (2007)

The Next Wave of Novel Agents in Aggressive B-Cell Lymphoma: Highlights From SOHO 2021
Publicado: (2022)

Collaborative Management of Patients With Estrogen Receptor–Positive Breast Cancer
por: Schwartzberg, Lee S., et al.
Publicado: (2017)

Precision autophagy: Will the next wave of selective autophagy markers and specific autophagy inhibitors feed clinical pipelines?
por: Lebovitz, Chandra B, et al.
Publicado: (2015)

Practical execution of defect preparation prior to surgical cartilage intervention: results from a representative meeting survey among experts
por: Salzmann, Gian M., et al.
Publicado: (2015)

Biomarker BINGO
por: Held, Lauren, et al.
Publicado: (2020)

Using next‐generation sequencing to redefine BRCAness in triple‐negative breast cancer
por: Lin, Po‐Han, et al.
Publicado: (2020)

Immunotherapy for early triple negative breast cancer: research agenda for the next decade
por: Tarantino, Paolo, et al.
Publicado: (2022)

Presentation and treatment of aggressive, Triple‐Negative carcinosarcoma of the breast
por: Vizgan, Niels, et al.
Publicado: (2022)

CIMT 2014: Next waves in cancer immunotherapy - Report on the 12th annual meeting of the Association for Cancer Immunotherapy: May 6–8 2014, Mainz, Germany
por: Diken, Mustafa, et al.
Publicado: (2014)

Iron for Africa—Report of an Expert Workshop
por: Mwangi, Martin N., et al.
Publicado: (2017)

Doxycycline for Malaria Chemoprophylaxis and Treatment: Report from the CDC Expert Meeting on Malaria Chemoprophylaxis
por: Tan, Kathrine R., et al.
Publicado: (2011)

Targeting EGFR in Triple Negative Breast Cancer
por: Ueno, Naoto T., et al.
Publicado: (2011)

Next generation sequencing of triple negative breast cancer to find predictors for chemotherapy response
por: Lips, Esther H., et al.
Publicado: (2015)

Targeted therapy for metastatic triple negative breast cancer: The next frontier in precision oncology
por: Vidula, Neelima, et al.
Publicado: (2017)

Olaparib in hormone receptor-positive, HER2-negative metastatic breast cancer with a somatic BRCA2 mutation
por: Schwartzberg, Lee S., et al.
Publicado: (2021)

Immunotherapy Treatment for Triple Negative Breast Cancer
por: Berger, Elizabeth R., et al.
Publicado: (2021)

Preparation, Characterization, and Inhibition of Hyaluronic Acid Oligosaccharides in Triple-Negative Breast Cancer
por: Han, Wenwei, et al.
Publicado: (2019)

Insights into the Role of Estrogen Receptor β in Triple-Negative Breast Cancer
por: Sellitto, Assunta, et al.
Publicado: (2020)

Expression of genes involved in DNA repair and cell cycle checkpoint pathways in Triple Negative compared to Luminal A Breast Cancer: a molecular characterization
por: Ganzinelli, Monica, et al.
Publicado: (2012)

Whose genome is next?
por: Kemmer, Danielle, et al.
Publicado: (2002)

Triple-Negative Lobular Breast Cancer Causing Hydronephrosis
por: Chahin, Michael, et al.
Publicado: (2020)

Management of triple negative breast cancer in a centenarian
por: Donaldson, Andrew, et al.
Publicado: (2022)

Bilateral Inflammatory Breast Cancer That Developed Two Years after Treatment for Triple-negative Breast Cancer
por: Kawaguchi, Yuta, et al.
Publicado: (2022)

Triple-Negative Breast Cancer
por: Chu, Quyen D., et al.
Publicado: (2012)

Triple-negative breast cancer
por: Chacón, Reinaldo D, et al.
Publicado: (2010)

Treatment options for patients with triple-negative breast cancer
por: Santana-Davila, Rafael, et al.
Publicado: (2010)

Current approaches in treatment of triple-negative breast cancer
por: Wahba, Hanan Ahmed, et al.
Publicado: (2015)

Targeting MYC for triple-negative breast cancer treatment
por: Klauber-DeMore, Nancy, et al.
Publicado: (2018)

Triple-negative breast cancer: recent treatment advances
por: Bergin, Alice R T, et al.
Publicado: (2019)

Triple-negative breast cancer: is there a treatment on the horizon?
por: Yao, Hui, et al.
Publicado: (2016)

Triple-negative breast cancer: treatment challenges and solutions
por: Collignon, Joëlle, et al.
Publicado: (2016)

Investigational Drug Treatments for Triple-Negative Breast Cancer
por: Damaskos, Christos, et al.
Publicado: (2021)

The advance of adjuvant treatment for triple-negative breast cancer
por: Ge, Jingyu, et al.
Publicado: (2022)

Modern Immunotherapy in the Treatment of Triple-Negative Breast Cancer
por: Wesolowski, Jakub, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_avrt5jjpmfhlaln7ecvh96ibsn